Dr Jacob Neathawk Jr, MD | |
1802 Braeburn Dr, Salem, VA 24153-7357 | |
(540) 772-3430 | |
(540) 776-2051 |
Full Name | Dr Jacob Neathawk Jr |
---|---|
Gender | Male |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 1802 Braeburn Dr, Salem, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558340869 | NPI | - | NPPES |
P00277033 | Other | VA | MEDICARE RAILROAD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 0101028129 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jacob Neathawk Jr, MD 1802 Braeburn Dr, Salem, VA 24153-7357 Ph: (540) 772-3430 | Dr Jacob Neathawk Jr, MD 1802 Braeburn Dr, Salem, VA 24153-7357 Ph: (540) 772-3430 |
News Archive
Dr Anders Nordstrom, Acting Director-General of the World Health Organization told delegates at the XVIth International AIDS Conference that "drastic measures" were required to ensure there are enough health workers available to deliver universal access to HIV/AIDS prevention, treatment, care and support by 2010.
In a paper published online this week in Autism Research, scientists at NeuroPointDX, a division of Stemina Biomarker Discovery, Inc., in collaboration with researchers at the UC Davis MIND Institute and academic and clinical institutions across the country, report new findings from the Children's Autism Metabolome Project or CAMP.
Indoor tanning appears to be common among non-Hispanic white female high school students and adults ages 18 to 34 years, according to a research letter by Gery P. Guy Jr., Ph.D., M.P.H., and colleagues at the Centers for Disease Control and Prevention, Atlanta, G.A.
Ipsen a global biopharmaceutical group, today announced that its partner Roche disclosed results of five Phase III 24-week studies for taspoglutide for type 2 diabetes at the American Diabetes Association's (ADA) 70th Annual Scientific Sessions. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
› Verified 8 days ago
John Weidner Knarr, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2155 Apperson Dr, Salem, VA 24153 Phone: 540-444-2010 Fax: 540-444-2019 | |
Jeffrey Blake Lipscomb, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-983-1011 | |
Dr. Andrew Maiolo, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1802 Braeburn Dr, Salem, VA 24153 Phone: 540-772-3430 Fax: 540-776-2051 | |
Dr. Charles John Schleupner, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1970 Roanoke Boulevard, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-855-3406 | |
Dr. Paul D Richards, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1900 Electric Rd, Salem, VA 24153 Phone: 540-774-8660 Fax: 540-774-9195 | |
Dr. Jane E Lindsay, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1900 Electric Rd, Salem, VA 24153 Phone: 540-728-0332 | |
Richard Prokopchak, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2850 Keagy Rd, Salem, VA 24153 Phone: 540-375-9375 Fax: 540-375-9376 |